A comparative molecular similarity index analysis (CoMSIA) study identifies an HLA-A2 binding supermotif.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 12602948)

Published in J Comput Aided Mol Des on February 26, 2003

Authors

Irini A Doytchinova1, Darren R Flower

Author Affiliations

1: Edward Jenner Istitute for Vaccine Research, Compton, Berkshire, RG20 7NN, UK.

Articles cited by this

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol (1994) 8.16

The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol (1995) 4.60

Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol (1991) 4.44

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell (1993) 3.80

Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem (1994) 3.60

The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 3.44

Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol (1992) 2.32

Definition of specific peptide motifs for four major HLA-A alleles. J Immunol (1994) 2.11

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol (1994) 1.80

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today (1996) 1.79

JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics (2002) 1.75

Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol (2001) 1.68

Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J Med Chem (1999) 1.62

Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol (1995) 1.35

Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J Proteome Res (2003) 1.23

Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des (1999) 1.17

Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. J Med Chem (2001) 1.17

Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. Hum Immunol (2000) 1.16

A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur J Immunol (2000) 1.14

Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08

FIMM, a database of functional molecular immunology. Nucleic Acids Res (2000) 1.06

The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. Biologicals (2002) 1.03

Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol (1995) 1.02

Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study. Proteins (2002) 1.00

Quantitative approaches to computational vaccinology. Immunol Cell Biol (2002) 0.82

The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes. J Biol Chem (1999) 0.82

Articles by these authors

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med (2004) 3.48

Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci (2004) 2.70

VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics (2007) 2.10

JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics (2002) 1.75

Identifiying human MHC supertypes using bioinformatic methods. J Immunol (2004) 1.72

JenPep: a novel computational information resource for immunobiology and vaccinology. J Chem Inf Comput Sci (2003) 1.64

Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201. J Med Chem (2005) 1.62

SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics (2006) 1.59

In silico identification of supertypes for class II MHCs. J Immunol (2005) 1.52

MHCPred: A server for quantitative prediction of peptide-MHC binding. Nucleic Acids Res (2003) 1.48

Benchmarking pK(a) prediction. BMC Biochem (2006) 1.47

Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores. BMC Bioinformatics (2006) 1.41

Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine (2006) 1.37

In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci U S A (2008) 1.34

EpiJen: a server for multistep T cell epitope prediction. BMC Bioinformatics (2006) 1.26

Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J Proteome Res (2003) 1.23

Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models. BMC Bioinformatics (2006) 1.22

Harnessing bioinformatics to discover new vaccines. Drug Discov Today (2007) 1.22

MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics (2003) 1.19

Bacterial bioinformatics: pathogenesis and the genome. J Mol Microbiol Biotechnol (2002) 1.18

AntigenDB: an immunoinformatics database of pathogen antigens. Nucleic Acids Res (2009) 1.18

Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. Trends Biotechnol (2008) 1.13

Towards the chemometric dissection of peptide--HLA-A*0201 binding affinity: comparison of local and global QSAR models. J Comput Aided Mol Des (2005) 1.11

PPD v1.0--an integrated, web-accessible database of experimentally determined protein pKa values. Nucleic Acids Res (2006) 1.10

Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog (2010) 1.06

FIMM, a database of functional molecular immunology: update 2002. Nucleic Acids Res (2002) 1.06

Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation. J Immunol (2004) 1.04

BPROMPT: A consensus server for membrane protein prediction. Nucleic Acids Res (2003) 1.03

On the hierarchical classification of G protein-coupled receptors. Bioinformatics (2007) 1.01

Quantitative online prediction of peptide binding to the major histocompatibility complex. J Mol Graph Model (2004) 1.01

Toward an atomistic understanding of the immune synapse: large-scale molecular dynamics simulation of a membrane-embedded TCR-pMHC-CD4 complex. Mol Immunol (2007) 1.01

LIPPRED: A web server for accurate prediction of lipoprotein signal sequences and cleavage sites. Bioinformation (2006) 1.01

Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study. Proteins (2002) 1.00

MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog (2010) 0.99

Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J Immunol (2003) 0.99

HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Eng (2003) 0.97

On the hydrophobicity of peptides: Comparing empirical predictions of peptide log P values. Bioinformation (2006) 0.97

Coupling in silico and in vitro analysis of peptide-MHC binding: a bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes. J Immunol (2004) 0.97

Molecular basis of peptide recognition by the TCR: affinity differences calculated using large scale computing. J Immunol (2005) 0.96

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J Gen Virol (2005) 0.95

Proteomic applications of automated GPCR classification. Proteomics (2007) 0.95

New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity. Org Biomol Chem (2004) 0.92

Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique. J Chem Inf Model (2006) 0.91

Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach. BMC Struct Biol (2011) 0.91

MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinformatics (2006) 0.90

Immunoinformatics. Predicting immunogenicity in silico. Preface. Methods Mol Biol (2007) 0.90

In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study. J Chem Inf Model (2005) 0.88

Peptide length significantly influences in vitro affinity for MHC class II molecules. Immunome Res (2008) 0.88

Large-scale molecular dynamics simulations of HLA-A*0201 complexed with a tumor-specific antigenic peptide: can the alpha3 and beta2m domains be neglected? J Comput Chem (2004) 0.88

Peptide recognition by the T cell receptor: comparison of binding free energies from thermodynamic integration, Poisson-Boltzmann and linear interaction energy approximations. Philos Trans A Math Phys Eng Sci (2005) 0.87

Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors. PLoS One (2009) 0.86

Class I T-cell epitope prediction: improvements using a combination of proteasome cleavage, TAP affinity, and MHC binding. Mol Immunol (2006) 0.86

Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. Eur J Med Chem (2009) 0.86

In silico prediction of peptide-MHC binding affinity using SVRMHC. Methods Mol Biol (2007) 0.85

Toward bacterial protein sub-cellular location prediction: single-class discrimminant models for all gram- and gram+ compartments. Bioinformation (2006) 0.85

Optimizing amino acid groupings for GPCR classification. Bioinformatics (2008) 0.84

Multi-class subcellular location prediction for bacterial proteins. Bioinformation (2006) 0.84

Toward the atomistic simulation of T cell epitopes automated construction of MHC: peptide structures for free energy calculations. J Mol Graph Model (2007) 0.84

Modeling the peptide-T cell receptor interaction by the comparative molecular similarity indices analysis-soft independent modeling of class analogy technique. J Med Chem (2006) 0.83

Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes. PLoS One (2009) 0.83

EpiTOP--a proteochemometric tool for MHC class II binding prediction. Bioinformatics (2010) 0.83

Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression. J Chem Inf Model (2007) 0.83

Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity. BMC Struct Biol (2006) 0.83

Immunoinformatic evaluation of multiple epitope ensembles as vaccine candidates: E coli 536. Bioinformation (2012) 0.82

GPCRTree: online hierarchical classification of GPCR function. BMC Res Notes (2008) 0.82

Quantitative approaches to computational vaccinology. Immunol Cell Biol (2002) 0.82

AllerTOP--a server for in silico prediction of allergens. BMC Bioinformatics (2013) 0.82

TATPred: a Bayesian method for the identification of twin arginine translocation pathway signal sequences. Bioinformation (2006) 0.81

Identification of the HLA-DM/HLA-DR interface. Mol Immunol (2007) 0.81

An update on the functional molecular immunology (FIMM) database. Appl Bioinformatics (2005) 0.81

Quantitative structure-activity relationships and the prediction of MHC supermotifs. Methods (2004) 0.80

Receptor-ligand binding sites and virtual screening. Curr Med Chem (2006) 0.79

Lipocalins in bioscience: the first family gathering. Bioessays (2004) 0.79

Combining algorithms to predict bacterial protein sub-cellular location: Parallel versus concurrent implementations. Bioinformation (2006) 0.79

A comparative molecular similarity indices (CoMSIA) study of peptide binding to the HLA-A3 superfamily. Bioorg Med Chem (2003) 0.79

Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Methods Mol Biol (2007) 0.79

Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. Am J Med Genet A (2003) 0.79

From 'perfect mix' to 'potion magique'-- regulatory T cells and anti-inflammatory cytokines as adjuvant targets. Nat Rev Microbiol (2008) 0.79

MHC Class II Binding Prediction-A Little Help from a Friend. J Biomed Biotechnol (2010) 0.78

Using databases and data mining in vaccinology. Expert Opin Drug Discov (2007) 0.78

Beta barrel trans-membrane proteins: Enhanced prediction using a Bayesian approach. Bioinformation (2006) 0.78

Empirical prediction of peptide octanol-water partition coefficients. Bioinformation (2006) 0.78

Static energy analysis of MHC class I and class II peptide-binding affinity. Methods Mol Biol (2007) 0.77

EpiDOCK: a molecular docking-based tool for MHC class II binding prediction. Protein Eng Des Sel (2013) 0.76

In silico identification of novel G protein coupled receptors. Methods Mol Biol (2009) 0.76

Molecular dynamics simulations: bring biomolecular structures alive on a computer. Methods Mol Biol (2007) 0.76

Histidine hydrogen bonding in MHC at pH 5 and pH 7 modeled by molecular docking and molecular dynamics simulations. Curr Comput Aided Drug Des (2014) 0.76

AllerTOP v.2--a server for in silico prediction of allergens. J Mol Model (2014) 0.76

Present perspectives on the automated classification of the G-protein coupled receptors (GPCRs) at the protein sequence level. Curr Top Med Chem (2011) 0.76

HLA-DP2 binding prediction by molecular dynamics simulations. Protein Sci (2011) 0.76

The classification of HLA supertypes by GRID/CPCA and hierarchical clustering methods. Methods Mol Biol (2007) 0.75

Discriminating antigen and non-antigen using proteome dissimilarity: bacterial antigens. Bioinformation (2010) 0.75

A predictor of membrane class: Discriminating alpha-helical and beta-barrel membrane proteins from non-membranous proteins. Bioinformation (2006) 0.75

Discriminating antigen and non-antigen using proteome dissimilarity III: tumour and parasite antigens. Bioinformation (2010) 0.75

Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking study. BMC Struct Biol (2012) 0.75

DSD--an integrated, web-accessible database of Dehydrogenase Enzyme Stereospecificities. BMC Bioinformatics (2005) 0.75

Discriminating antigen and non-antigen using proteome dissimilarity II: viral and fungal antigens. Bioinformation (2010) 0.75

Alpha helical trans-membrane proteins: Enhanced prediction using a Bayesian approach. Bioinformation (2006) 0.75